Stay updated on Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Sign up to get notified when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.

Latest updates to the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page
- CheckyesterdayChange DetectedLocations section consolidated and expanded to include multiple study sites across the US and Canada, with revision tag updated to v3.3.3.SummaryDifference1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA minor version update was applied (from v3.3.1 to v3.3.2); no user-visible content changes were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check30 days agoChange DetectedRevision update from v3.2.0 to v3.3.1 with no changes to trial details, eligibility, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedNotice about potential government funding delays and NIH operating status has been removed from the page.SummaryDifference0.3%

- Check52 days agoChange DetectedThe screenshots show only minor visual or layout adjustments (such as header styling) with no changes to core study data like PPP criteria, primary/secondary outcomes, enrollment numbers, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check80 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference4%

Stay in the know with updates to Imsidolimab for Palmoplantar Pustulosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Imsidolimab for Palmoplantar Pustulosis Clinical Trial page.